Allscripts (MDRX) Shares Jump on Analyst Upgrade to Outperform
MDRX Hot Sheet
Rating Summary:5 Buy, 16 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
An analyst at Raymond James is moving shares of Allscripts-Misys Healthcare Solutions (Nasdaq: MDRX) today following an upgrade from Market Perform to Outperform earlier. The stock has spiked nearly 13% on extremely heavy volume. Average daily volume in the health care stock is around 1.24 million shares, but it has already traded more than 4 million times today.
To see all the analyst calls on shares of Allscripts, click here or go to http://www.streetinsider.com/stock_lookup_news.php?q=mdrx&type=analyst.
Allscripts-Misys Healthcare Solutions, Inc. offers software, services, information, and connectivity solutions that enable physicians and other healthcare providers to deliver patient safety and clinical outcomes primarily in the United States.
To see all the analyst calls on shares of Allscripts, click here or go to http://www.streetinsider.com/stock_lookup_news.php?q=mdrx&type=analyst.
Allscripts-Misys Healthcare Solutions, Inc. offers software, services, information, and connectivity solutions that enable physicians and other healthcare providers to deliver patient safety and clinical outcomes primarily in the United States.
You May Also Be Interested In
- UPDATE: UBS Upgrades Westlake Chemical (WLK) to Neutral; Fairly Valued Now
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Allscripts Healthcare Solutions, Inc. to Contact the Firm
- UPDATE: Nomura Securities Upgrades Central European Distribution (CEDC) to Neutral; Strategic Alliance with Russian Standard
Create E-mail Alert Related Categories
UpgradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
